Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Market Size of the Deep Learning In Drug Discovery And Diagnostics Market In 2029?
The market for deep learning in drug discovery and diagnostics has seen a significant expansion in recent times. The market is projected to expand from $8.21 billion in 2024 to $10.58 billion in 2025, with a compound annual growth rate (CAGR) of 28.8%. The historical growth is as a result of several factors such as increased investments into AI research, a surged demand for bespoke medicine, increased public and private funding, rise in chronic and complex conditions, and an increased uptake of electronic health records.
What Growth Rate Is Forecasted for the Deep Learning In Drug Discovery And Diagnostics Market by 2029?
The market size of deep learning in drug discovery and diagnostics is predicted to experience substantial expansion in the coming years, reaching a value of $28.82 billion in 2029, with a compound annual growth rate (CAGR) of 28.5%. Factors contributing to the projected growth during this period include enhanced diagnostic precision, increased partnerships between tech enterprises and pharmaceutical companies, advancements in explainable AI (xai) for superior model transparency, heightened focus on real-world evidence (RWE), and growth in emerging markets. Key trends anticipated in this period involve the uptake of AI technologies, advancements in computing power, adoption of big data, development of innovative deep learning architectures, and proliferation of cloud-based platforms for AI technology.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19394&type=smp
Which Key Companies Are Shaping the Future of the Deep Learning In Drug Discovery And Diagnostics Market?
Major companies operating in the deep learning in drug discovery and diagnostics market are Google Inc., Microsoft Corporation, International Business Machines Corporation, NVIDIA Corporation, Zebra Medical Vision Ltd., Tempus Labs Inc., Nanostring Technologies Inc., Owkin Inc., Insilico Medicine Inc., SOPHiA GENETICS SA, Qureai Technologies Pvt Ltd., H2Oai Inc., Arterys Inc., Deep Genomics Inc., GNS Healthcare Inc., MedAware Systems Inc., PathAI Inc., Kheiron Medical Technologies Ltd., CureMetrix Inc., OncoImmunity AS, Proscia Inc., BenevolentAI Ltd., BioXcel Therapeutics Inc.
Which Factors Are Driving Demand in the Deep Learning In Drug Discovery And Diagnostics Industry?
The surge in interest for custom-made medications is projected to boost the expansion of the deep learning in drug discovery and diagnostics market. Personalized medicine customizes healthcare treatments and procedures to fit the distinctive genetic, environmental, and lifestyle aspects of each patient, with the aim to optimise effectiveness and reduce side effects. The increasing demand for personalized medicine is bolstered by enhancements in genomics and data analytics that allow for more accurate and efficient treatments designed for specific patient profiles. By analyzing intricate biological data, deep learning in drug discovery and diagnostics improves custom-made medical care by identifying distinct biomarkers and forecasting patient reactions to treatments with more precision. As an example, the Personalized Medicine Coalition, a non-profit organization based in the US, reported in February 2024 that the FDA had approved 16 new personalized remedies for patients with rare diseases in 2023 as compared to only six in 2022. Therefore, it is the escalating demand for personalized medicine that is the driving force behind deep learning in drug discovery and diagnostics market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=19394&type=smp
How Is the Deep Learning In Drug Discovery And Diagnostics Market Segmented by Several Divisions?
The deep learning in drug discovery and diagnosticsmarket covered in this report is segmented –
1) By Type: Drug Discovery, Diagnostics, Forensic Interventions, Other Types
2) By Drug Type: Small Molecule Drugs, Biologics Drugs
3) By End Use Industry: Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Healthcare Information Technology (IT)
Subsegments:
1) By Drug Discovery: Target Identification, Drug Screening, Lead Optimization, Predictive Modeling
2) By Diagnostics: Medical Imaging Analysis, Genomic Data Interpretation, Disease Detection Algorithms, Personalized Medicine
3) By Forensic Interventions: Digital Pathology, Forensic DNA Analysis, Toxicology Screening, Crime Scene Reconstruction
4) By Other Types: Biomarker Discovery, Predictive Analytics in Healthcare, Patient Data Management Systems
What are the Emerging Market Trends Driving the Growth of the Deep Learning In Drug Discovery And Diagnostics Industry?
Major companies operating in the deep learning in drug discovery and diagnostics market are focusing on the advancement of high-performance computing technologies, such as supercomputers, to accelerate innovation through improved performance and efficiency in complex tasks and AI applications. Advancements in supercomputers enhance deep learning in drug discovery and diagnostics by speeding up complex data analysis and simulations, leading to faster identification of drug candidates and more accurate diagnostics. For instance, in November 2022, Hewlett-Packard Enterprise, a US-based information technology company, introduced the HPE Cray EX and HPE Cray XD supercomputers. These new systems offer powerful performance and AI-at-scale capabilities in a more compact and cost-efficient design, aimed at accelerating drug discovery and speeding up disease treatments. This enables research scientists and pharmaceutical labs to gain deeper insights into chemical interactions, fostering the development of innovative drug therapies for both challenging and newly emerging diseases.
Access The Full Report Here:
Which Regions Are Driving Growth in the Deep Learning In Drug Discovery And Diagnostics Market?
North America was the largest region in the deep learning in drug discovery and diagnostics market in 2024. The regions covered in the deep learning in drug discovery and diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19394
This Report Delivers Insight On:
1. How big is the deep learning in drug discovery and diagnostics market, and how is it changing globally?
2. Who are the major companies in the deep learning in drug discovery and diagnostics market, and how are they performing?
3. What are the key opportunities and risks in the deep learning in drug discovery and diagnostics market right now?
4. Which products or customer segments are growing the most in the deep learning in drug discovery and diagnostics market?
5. What factors are helping or slowing down the growth of the deep learning in drug discovery and diagnostics market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model